CC BY-NC-ND 4.0 · Geburtshilfe Frauenheilkd 2017; 77(11): 1157-1173
DOI: 10.1055/s-0043-118908
GebFra Science
Guideline/Leitlinie
Georg Thieme Verlag KG Stuttgart · New York

Intrauterine Growth Restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015/080, October 2016)

Article in several languages: English | deutsch
Sven Kehl
1   Frauenklinik, Universitätsklinikum Erlangen, Erlangen, Germany
,
Jörg Dötsch
2   Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum Köln, Köln, Germany
,
Kurt Hecher
3   Klinik für Geburtshilfe und Pränatalmedizin, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
,
Dietmar Schlembach
4   Klinik für Geburtsmedizin, Vivantes Klinikum Neukölln, Berlin, Germany
,
Dagmar Schmitz
5   Institut für Geschichte, Theorie und Ethik der Medizin, Uniklinik RWTH Aachen, Aachen, Germany
,
Holger Stepan
6   Abteilung für Geburtsmedizin, Universitätsklinikum Leipzig, Leipzig, Germany
,
Ulrich Gembruch
7   Abteilung für Geburtshilfe und Pränatale Medizin, Universitätsklinikum Bonn, Bonn, Germany
› Author Affiliations
Further Information

Publication History

received 19 August 2017
revised 19 August 2017

accepted 25 August 2017

Publication Date:
27 November 2017 (online)

Abstract

Aims The aim of this official guideline published and coordinated by the German Society of Gynecology and Obstetrics (DGGG) was to provide consensus-based recommendations obtained by evaluating the relevant literature for the diagnostic treatment and management of women with fetal growth restriction.

Methods This S2k guideline represents the structured consensus of a representative panel of experts with a range of different professional backgrounds commissioned by the Guideline Committee of the DGGG.

Recommendations Recommendations for diagnostic treatment, management, counselling, prophylaxis and screening are presented.